slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 40,381-40,410
Pages 2,605
Rows per page 30
Component
40,381-40,410 of 78,129
10
The chart uses arrows to imply a cumulative or compounding effect of the initiatives on the conversion rate.06.10.2022 MS Financials Conference · Morgan Stanley
Consulting deck Equity research Beat · ActionLoop · Cost Of Inaction1 hit
13
The slide displays 11 individual line charts for different sectors and one summary table.350e000c acff 48f1 ab1e fc2abe7a5f3c · Goldman Sachs
Consulting deck Equity research Beat · Evidence1 hit
14
The charts track relative performance from Dec-22 to early 2024.350e000c acff 48f1 ab1e fc2abe7a5f3c · Goldman Sachs
Consulting deck Equity research Beat · Evidence1 hit
15
The charts display performance from Dec-22 to early 2024. Each chart includes a list of the three largest stocks in that industry group with their respective weights.350e000c acff 48f1 ab1e fc2abe7a5f3c · Goldman Sachs
Consulting deck Equity research Beat · Evidence1 hit
18
The slide presents a comprehensive table of GS portfolio strategy baskets with performance data (1wk, 1mo, YTD) and valuation metrics (P/E, EV/Sales, '23 EPS growth).350e000c acff 48f1 ab1e fc2abe7a5f3c · Goldman Sachs
Consulting deck Equity research Beat · Evidence1 hit
14
The slide uses a bar chart to show production capacity relative to competitors and a map to show brand distribution from the central Louisiana hub.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Product1 hit
19
The chart is a classic cost-curve or supply-stack analysis showing MRL's position relative to competitors.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Loop · Why Now1 hit
21
Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research 1 hit
25
The chart highlights the impact of an RVO announcement on the margin.Calumet+Inc.+Carbonomics+Investor+Presentation+Final+11+Nov.+'24 · Calumet
Consulting deck Equity research Beat · Team1 hit
16
The slide uses a timeline-based visual to contrast injection frequency across five different pharmaceutical products.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
19
The chart compares DURAVYU 2.7mg, 1.3mg, and aflibercept 2mg. A red box highlights the early improvement at Week 4.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
20
The outlier patient missed multiple visits, leading to significant vision loss at week 24.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
21
The chart compares DURAVYU 2.7mg, DURAVYU 1.3mg, and Aflibercept 2mg. The final values at Week 24 are highlighted in a box.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
11
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research Loop · Zoom In1 hit
12
Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare ConferenceFresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research Loop · Zoom In1 hit
15
The chart uses a broken axis between 2009 and 2019.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research Loop · Cost Of Inaction1 hit
31
The chart shows a combo bar-line chart for revenue and EBIT margin, with a table below for revenue growth and EBIT in million euros.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research Beat · Visualization1 hit
32
The slide uses a combination of a bar-line chart for revenue and margin, and a table for growth and EBIT metrics.Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference · Fresenius
Consulting deck Equity research Beat · Visualization1 hit
03
Includes Morgan Stanley branding; data as of 12/25 and 06/25.gol 6 · Morgan Stanley
Consulting deck Equity research Loop · Benchmark Gap1 hit
04
Financial performance report for Morgan Stanley investment program.gol 6 · Morgan Stanley
Consulting deck Equity research Loop · Benchmark Gap1 hit
07
The slide discusses the benefits of a factor-based approach to portfolio diversification over traditional asset class labels.Goldman Sachs Ayco Outlook 2024 Webinar Materials · Goldman Sachs
Consulting deck Equity research Beat · Evidence & ProofLoop · Zoom In1 hit
10
The chart illustrates the impact of leverage and factor-based diversification on portfolio performance.Goldman Sachs Ayco Outlook 2024 Webinar Materials · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next StepsLoop · Mece Breakdown1 hit
05
The slide uses a circular diagram to show shared responsibilities and a line chart to show the revenue lifecycle of an OEM project.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research Beat · Product1 hit
13
The slide uses a standard financial reporting format with a bar chart and a bulleted list of qualitative drivers.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research Beat · FinancialsLoop · Cost Of Inaction1 hit
14
The chart uses a combination of bar (EBIT) and line (Margin) to visualize financial performance over time.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research Beat · FinancialsLoop · Cost Of Inaction1 hit
22
Includes pie chart of ownership split and list of institutional investors > 3%.GOLDMAN SACHS MEDTECH AND HEALTHCARE SERVICES CONFERENCE · Stratec
Consulting deck Equity research 1 hit
11
The chart uses a waterfall structure to bridge the beginning and ending NAV per share, accounting for income, dividends, and realized/unrealized losses.GSBD Investor Presentation Q1 2023 vF · Goldman Sachs
Consulting deck Equity research Beat · Solution1 hit
13
The chart tracks dividend history from Sep-19 to Sep-25. The table provides stock price data for the last 12 quarters.GSBD Investor Presentation Q1 2023 vF · Goldman Sachs
Consulting deck Equity research Beat · Solution1 hit
12
The slide title is 'Net Income', but the action title is the primary takeaway.why invest in goldman sachs · St. John's University Student Managed Investment Fund
Consulting deck Equity research Beat · FinancialsLoop · Benchmark Gap1 hit
19
The slide contains a line chart for financial leverage and a data table for DuPont analysis components (Net Profit Margin, Asset Turnover, Financial Leverage, ROE).why invest in goldman sachs · St. John's University Student Managed Investment Fund
Consulting deck Equity research Beat · FinancialsLoop · Benchmark Gap1 hit